Spruce Biosciences Inc. (NASDAQ: SPRB)
$0.59
+0.0110 ( +1.90% ) 431.9K
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).
Market Data
Open
$0.59
Previous close
$0.58
Volume
431.9K
Market cap
$24.31M
Day range
$0.58 - $0.60
52 week range
$0.50 - $5.95
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 52 | May 13, 2024 |
8-k | 8K-related | 12 | May 13, 2024 |
8-k | 8K-related | 11 | Apr 30, 2024 |
ars | Annual reports | 1 | Apr 05, 2024 |
def | Proxies and info statements | 6 | Apr 05, 2024 |
4 | Insider transactions | 1 | Mar 25, 2024 |
4 | Insider transactions | 1 | Mar 20, 2024 |
4 | Insider transactions | 1 | Mar 18, 2024 |
10-k | Annual reports | 101 | Mar 18, 2024 |
4 | Insider transactions | 1 | Mar 18, 2024 |